2024-06-03T09:52:19-05:00 2023-12-31 221478099 COHNREZNICK LLP 500 EAST PRATT STREET 4TH FLOOR BALTIMORE MD 21202 990 2023-01-01 221950891 AMERICAN COLLEGE OF CLINICAL PHARMACOLOGY INC AMER 2403999070 PO BOX 1758 ASHBURN VA 20146 DIONNA GREEN MD PRESIDENT 2403999070 2024-05-29 1 DIONNA GREEN MD XXX-XX-XXXX 0 LORI ROTHE YOKOBOSKY CPA P01273422 4107834900 2024-05-28 2 AAL1 IAL1 2023 2023-04-26 12:10:37Z DIONNA GREEN MD PO BOX 1758 ASHBURN VA 20146 5149348 0 X WWW.ACCP1.ORG X 1969 NY TO ADVANCE THE SCIENCE OF CLINICAL PHARMACOLOGY IN ALL ITS PHASES AND ENGAGE IN APPROPRIATE EDUCATIONAL EFFORTS IN THE PUBLIC INTEREST. 17 16 7 275 9308 4684 4225 100 1659579 1691496 207460 347736 0 0 1871264 2039332 0 0 0 0 640958 657453 0 0 0 869591 1088749 1510549 1746202 360715 293130 8134708 9039685 231190 318433 7903518 8721252 X TO IMPROVE HEALTH BY OPTIMIZING THERAPEUTICS; PROVIDE INNOVATIVE LEADERSHIP AND INTERDISCIPLINARY EDUCATION THAT WILL ENABLE THE GENERATION, INTEGRATION AND TRANSLATION OF SCIENTIFIC KNOWLEDGE TO OPTIMIZE RESEARCH, DEVELOPMENT AND UTILIZATION OF MEDICATION FOR THE BENEFIT OF ALL. 0 0 918801 781780 TO ENHANCE THE KNOWLEDGE, SKILLS AND PROFESSIONAL PRACTICE OF PHYSICIANS, SCIENTISTS, PHARMACISTS AND OTHER HEALTHCARE PROFESSIONALS WHO ARE INVOLVED IN DRUG DEVELOPMENT AND THE EVALUATION AND/OR TREATMENT OF PATIENTS. THE EDUCATION PROGRAM IS DESIGNED TO HELP PHYSICIANS, SCIENTISTS, PHARMACISTS AND OTHER HEALTHCARE PROFESSIONALS FOCUS ON QUALITY IMPROVEMENT AND PRACTICE EVIDENCE-BASED MEDICINE IN THE DEVELOPMENT AND EVALUATION OF PHARMACEUTICALS AND BIOLOGICS AND THE DELIVERY OF PATIENT-CENTERED CARE. 243857 900408 PUBLICATION OF "THE JOURNAL OF CLINICAL PHARMACOLOGY AND "CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT" OF HIGH-QUALITY CLINICAL PHARMACOLOGY STUDIES IN DRUG DEVELOPMENT WHICH ARE PRIMARILY (BUT NOT EXCLUSIVELY) PERFORMED IN EARLY DEVELOPMENT PHASES IN HEALTHY SUBJECTS. PROMOTE AWARENESS OF AND PROVIDE SERVICES TO THE PROFESSION OFCLINICAL PHARMACOLOGY. 1162658 1 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 19 0 1 7 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 17 16 1 0 0 0 0 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 0 X CATHERINE M PENNINGTON LLC 7038610009 9801 WOODLEIGH LANE APT ES 305 FAIRFAX VA 22032 DONALD E MAGER PHARMD PHD FCP IMMEDIATE PAST PRESIDENT 5.00 X X 0 0 0 DIONNA GREEN MD PRESIDENT 1.00 X X 0 0 0 OLIVER GRUNDMANN PHD PRESIDENT ELECT 1.00 X X 0 0 0 NAVI GOYAL PHD REGENT 1.00 X 0 0 0 MICHAEL J FOSSLER JR COUNCILOR 1.00 X X 0 0 0 KRISTA L LEVY EXECUTIVE DIRECTOR 40.00 X X 214888 0 18438 CRAIG HENDRIX MD REGENT 1.00 X 0 0 0 OTITO IWUCHUKWU PHD SECRETARY 1.00 X X 0 0 0 CATHERIJNE KNIBBE PHARMD PHD REGENT 1.00 X 0 0 0 LUCY LEE PHARMD REGENT 1.00 X 0 0 0 THOMAS NOLIN PHARMD PHD TREASURER 1.00 X X 0 0 0 NATELLA Y RAKHMANINA MD PHD REGENT 1.00 X 0 0 0 ARUN RAM MD REGENT 1.00 X 0 0 0 STEPHAN SCHMIDT BPHARM PHD REGENT 1.00 X 0 0 0 PETER WIERNIK MD REGENT 1.00 X 0 0 0 LORRAINE RUSCH PHD REGENT 1.00 X 0 0 0 MATTHEW B DUFEK PHD REGENT 1.00 X 0 0 0 MYONG-JIN KIM PHARMD REGENT 1.00 X 0 0 0 JEAN-MICHEL GRIES REGENT 1.00 X 0 0 0 MARK ROGGE REGENT 1.00 X 0 0 0 NEERAJ GUPTA REGENT 1.00 X 0 0 0 VIJAY UPRETI REGENT 1.00 X 0 0 0 DIANE R MOULD REGENT 1.00 X 0 0 0 ANNE PACCALY REGENT 1.00 X 0 0 0 214888 0 18438 1 0 1 0 0 100 100 JOURNAL REVENUE 900099 900408 900408 ANNUAL MEETINGS 900099 568895 568895 MEMBERSHIP DUES 900099 210655 210655 WEBSITE CAREER CENTER 900099 9308 9308 2230 2230 1691496 228668 228668 3229084 3110016 119068 119068 119068 2039332 1682188 9308 347736 233326 151662 81664 367905 174685 193220 19768 12800 6968 36454 23604 12850 45550 45550 9869 9869 58969 58969 24102 19312 4790 69726 7699 62027 96489 44608 51881 39537 19127 20410 436357 436357 4512 4512 JOURNAL PUBLICATION 243857 243857 ACCREDITATION 30390 28775 1615 BOARD & COMMITTEE 23021 23021 6370 172 6198 1746202 1162658 583544 0 1497583 1498743 2794 2455 113100 142804 175489 25326 53041 150163 6466494 7243824 1696 1696 8134708 9039685 45574 37163 142640 139005 42976 142265 231190 318433 X 7893213 8710947 10305 10305 7903518 8721252 8134708 9039685 293130 571887 -47283 0 X 0 1 X 1 0 X 3636 300 56064 4225 100 64325 1402159 1158930 1344473 1648495 1682188 7236245 1405795 1159230 1400537 1652720 1682288 7300570 0 0 0 7300570 143733 153805 217556 194223 228668 937985 4562 4439 8866 11084 9308 38259 148295 158244 226422 205307 237976 976244 336 115 451 1554426 1317589 1626959 1858027 1920264 8277265 0.88200 0.88820 0.11790 0.11180 X 175489 25326 150163 150163 OTHER LIABILITIES 300 LEASE LIABILITY 141965 142265 X 2563936 571887 571887 1992049 47283 47283 2039332 1746202 0 1746202 0 1746202 PART X, LINE 2: THE COLLEGE HAS RECEIVED A DETERMINATION LETTER FROM THE INTERNAL REVENUE SERVICE ("IRS") TO BE TREATED AS A TAX-EXEMPT ENTITY PURSUANT TO SECTION 501(C)(3) OF THE CODE. THE COLLEGE EARNS COMMISSION REVENUE THROUGH CAREER CENTER SERVICES OFFERED THROUGH ITS WEBSITE AND FOR ADVERTISEMENTS PLACED ON ITS WEBSITE. THE COLLEGE CONSIDERS THIS REVENUE TO BE UNRELATED TO ITS EXEMPT PURPOSE; AND THEREFORE, IT IS DEEMED TAXABLE. FOR THE YEAR ENDED DECEMBER 31, 2023, THE COLLEGE HAD UNRELATED BUSINESS INCOME OF $9,308, RESULTING IN UNRELATED BUSINESS INCOME TAX OF $0. HOWEVER, DURING 2023, THE COLLEGE PAID $1,320 IN ESTIMATED TAX PAYMENTS. A REFUND FOR INCOME TAXES OF $336 HAS BEEN RECORDED IN THE ACCOMPANYING FINANCIAL STATEMENTS AS A COMPONENT OF ACCOUNTS RECEIVABLE, NET FOR THE YEAR ENDED DECEMBER 31, 2023. FOR THE YEAR ENDED DECEMBER 31, 2022, THE COLLEGE HAD UNRELATED BUSINESS INCOME OF $11,084, RESULTING IN UNRELATED BUSINESS INCOME TAX OF $1,314. THE COLLEGE PAID NO ESTIMATED TAX PAYMENTS DURING THE YEAR ENDED DECEMBER 31, 2022. ACCORDINGLY, A PROVISION FOR INCOME TAXES OF $1,314 HAS BEEN RECORDED IN THE ACCOMPANYING FINANCIAL STATEMENTS AS A COMPONENT OF ACCRUED EXPENSES AND OTHER LIABILITIES FOR THE YEAR ENDED DECEMBER 31, 2023. THE COLLEGE IS REQUIRED TO FILE AND DOES FILE TAX RETURNS WITH THE IRS. WHILE NO INCOME TAX RETURNS ARE CURRENTLY BEING EXAMINED BY THE IRS, TAX YEARS SINCE 2020 REMAIN OPEN FOR EXAMINATION. X X 0 0 0 0 0 0 0 0 0 KRISTA L LEVY EXECUTIVE DIRECTOR 183680 0 10000 0 21208 0 6523 0 11915 0 233326 0 0 0 PART I, LINE 3 COMPENSATION FOR THE EXECUTIVE DIRECTOR WAS ASSESSED BY A SALARY SURVEY AND BY APPROVAL OF THE BOARD FORM 990, PART VI, SECTION A, LINE 2 ANNE NAFZIGER, REGENT, IS MARRIED TO JOSEPH S. BERTINO, EDITOR-IN-CHIEF. NATELLA RAKHMANINA IS MARRIED TO JOHN VAN DEN ANKER, BOTH ARE REGENTS. FORM 990, PART VI, SECTION A, LINE 7A VOTING MEMBERS OF THE SOCIETY, AS DESCRIBED BY THE CONSTITUTION, ELECT THE MEMBERS OF THE GOVERNING BODY. ANY DECISION REGARDING DISSOLUTION OF THE SOCIETY WOULD REQUIRE THE APPROVAL OF THE MEMBERSHIP. FORM 990, PART VI, SECTION A, LINE 7B VOTING MEMBERS OF THE SOCIETY, AS DESCRIBED BY THE CONSTITUTION, ELECT THE MEMBERS OF THE GOVERNING BODY. ANY DECISION REGARDING DISSOLUTION OF THE SOCIETY WOULD REQUIRE THE APPROVAL OF THE MEMBERSHIP. FORM 990, PART VI, SECTION B, LINE 11B THE 990 IS REVIEWED BY THE EXECUTIVE COMMITTEE AND EXECUTIVE DIRECTOR AND, AS REQUESTED, BY THE BOARD. FORM 990, PART VI, SECTION B, LINE 12C COIS ARE SIGNED ANNUALLY IN JANUARY BY STAFF AND MEMBERS OF THE GOVERNING BODY. THE COMPLIANCE SUBCOMMITTEE ACTIVELY MONITORS AND ENFORCES THE COI POLICY, INCLUDING A REVIEW FOR POTENTIAL CONFLICTS PRIOR TO EACH MEETING. FORM 990, PART VI, SECTION B, LINE 15 COMPENSATION FOR THE ORGANIZATION'S EXECUTIVE DIRECTOR IS ESTABLISHED AND APPROVED BY THE BOARD. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST TO THE PUBLIC. PART VI LINE 10 EACH CHAPTER HAS BYLAWS FOR GOVERNANCE THAT ARE CONSISTENT WITH ACCP'S MISSION. ANNUAL REPORTS ARE PROVIDED BY THE CHAPTERS. AT THIS POINT, FUNDS PROVIDED TO THE CHAPTERS ARE DONE ON AN EXPENSE REIMBURSEMENT BASIS.